NCT03050099View on ClinicalTrials.gov

SpecTRA; An Observational Study of the Verification of Protein Biomarkers in Transient Ischemic Attack.

CompletedOBSERVATIONAL
Enrollment

560

Participants

Timeline

Start Date

December 1, 2013

Primary Completion Date

June 30, 2015

Study Completion Date

December 31, 2016

Conditions
TIA
Interventions
OTHER

Non-Interventional Study

This is a non-interventional study. However, several blood samples will be taken which would not be taken as part of standard of care.

Trial Locations (2)

T2N 2T9

Foothills Medical Centre, Calgary

V8R 1J8

Vancouver Island Health Authority, Victoria

Sponsors

Collaborators (1)

LifeLabs
All Listed Sponsors
collaborator

Genome Canada

OTHER

collaborator

Genome British Columbia

INDUSTRY

collaborator

Genome Alberta

OTHER

collaborator

Heart and Stroke Foundation of Canada

OTHER

collaborator

Stroke Services BC

UNKNOWN

collaborator

Bruker Daltonics

INDUSTRY

collaborator

LifeLabs

UNKNOWN

lead

Andrew Penn

OTHER

NCT03050099 - SpecTRA; An Observational Study of the Verification of Protein Biomarkers in Transient Ischemic Attack. | Biotech Hunter | Biotech Hunter